Skip to main content
Journal cover image

Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease.

Publication ,  Journal Article
Goggi, JL; Qiu, L; Liao, MC; Khanapur, S; Jiang, L; Boominathan, R; Hartimath, SV; Cheng, P; Yong, FF; Soh, V; Deng, X; Lin, YM; Haslop, A ...
Published in: Stem cell research & therapy
August 2020

Significant developments in stem cell therapy for Parkinson's disease (PD) have already been achieved; however, methods for reliable assessment of dopamine neuron maturation in vivo are lacking. Establishing the efficacy of new cellular therapies using non-invasive methodologies will be critical for future regulatory approval and application. The current study examines the utility of neuroimaging to characterise the in vivo maturation, innervation and functional dopamine release of transplanted human embryonic stem cell-derived midbrain dopaminergic neurons (hESC-mDAs) in a preclinical model of PD.Female NIH RNu rats received a unilateral stereotaxic injection of 6-OHDA into the left medial forebrain bundle to create the PD lesion. hESC-mDA cell and sham transplantations were carried out 1 month post-lesion, with treated animals receiving approximately 4 × 105 cells per transplantation. Behavioural analysis, [18F]FBCTT and [18F]fallypride microPET/CT, was conducted at 1, 3 and 6 months post-transplantation and compared with histological characterisation at 6 months.PET imaging revealed transplant survival and maturation into functional dopaminergic neurons. [18F]FBCTT-PET/CT dopamine transporter (DAT) imaging demonstrated pre-synaptic restoration and [18F]fallypride-PET/CT indicated functional dopamine release, whilst amphetamine-induced rotation showed significant behavioural recovery. Moreover, histology revealed that the grafted cells matured differently in vivo producing high- and low-tyrosine hydroxylase (TH) expressing cohorts, and only [18F]FBCTT uptake was well correlated with differentiation.This study provides further evidence for the value of in vivo functional imaging for the assessment of cell therapies and highlights the utility of DAT imaging for the determination of early post-transplant cell maturation and differentiation of hESC-mDAs.

Duke Scholars

Published In

Stem cell research & therapy

DOI

EISSN

1757-6512

ISSN

1757-6512

Publication Date

August 2020

Volume

11

Issue

1

Start / End Page

347

Related Subject Headings

  • Rats
  • Positron Emission Tomography Computed Tomography
  • Parkinson Disease
  • Oxidopamine
  • Neuroimaging
  • Female
  • Dopaminergic Neurons
  • Dopamine Plasma Membrane Transport Proteins
  • Disease Models, Animal
  • Animals
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goggi, J. L., Qiu, L., Liao, M. C., Khanapur, S., Jiang, L., Boominathan, R., … Robins, E. G. (2020). Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease. Stem Cell Research & Therapy, 11(1), 347. https://doi.org/10.1186/s13287-020-01868-4
Goggi, Julian L., Lifeng Qiu, Mei Chih Liao, Shivashankar Khanapur, Lingfan Jiang, Ramasamy Boominathan, Siddesh V. Hartimath, et al. “Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease.Stem Cell Research & Therapy 11, no. 1 (August 2020): 347. https://doi.org/10.1186/s13287-020-01868-4.
Goggi JL, Qiu L, Liao MC, Khanapur S, Jiang L, Boominathan R, et al. Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease. Stem cell research & therapy. 2020 Aug;11(1):347.
Goggi, Julian L., et al. “Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease.Stem Cell Research & Therapy, vol. 11, no. 1, Aug. 2020, p. 347. Epmc, doi:10.1186/s13287-020-01868-4.
Goggi JL, Qiu L, Liao MC, Khanapur S, Jiang L, Boominathan R, Hartimath SV, Cheng P, Yong FF, Soh V, Deng X, Lin YM, Haslop A, Tan PW, Zeng X, Lee JWL, Zhang Z, Sadasivam P, Tan EK, Luthra SK, Shingleton WD, Oh SKW, Zeng L, Robins EG. Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease. Stem cell research & therapy. 2020 Aug;11(1):347.
Journal cover image

Published In

Stem cell research & therapy

DOI

EISSN

1757-6512

ISSN

1757-6512

Publication Date

August 2020

Volume

11

Issue

1

Start / End Page

347

Related Subject Headings

  • Rats
  • Positron Emission Tomography Computed Tomography
  • Parkinson Disease
  • Oxidopamine
  • Neuroimaging
  • Female
  • Dopaminergic Neurons
  • Dopamine Plasma Membrane Transport Proteins
  • Disease Models, Animal
  • Animals